Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre

被引:33
作者
Tveiten, A. [1 ]
Mygland, A. [1 ,3 ,4 ]
Ljostad, U. [1 ]
Thomassen, L. [2 ]
机构
[1] Sorlandet Sykehus Kristiansand, Dept Neurol, N-4604 Kristiansand, Norway
[2] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway
[3] Univ Bergen, Inst Clin Med, Bergen, Norway
[4] Rikshosp Univ Hosp, Hosp Rehabil, Kristiansand, Norway
关键词
TIME WINDOW;
D O I
10.1136/emj.2008.063610
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Aim: To evaluate hospital delays in thrombolytic treatment before and after organisational changes and community-based treatment rates in a previously inexperienced centre. Methods: The delays before and after organisational changes made in 2006 were compared using a prospective treatment database. In a 6-month period in 2007, a community-based search was performed for all hospitalisations for ischaemic stroke. The number of patients admitted within the 0-3 h time window and the proportion treated with tissue plasminogen activator were analysed. Results: The number of treatments increased fourfold from 2005 to 2007 with a significant reduction in mean door-to-needle time from 60 min to 38 min (p=0.002). In the community-based series, 14/137 patients (10%) hospitalised with ischaemic stroke and 13/32 patients (41%) admitted in the 0-3 h window were treated. Conclusions: An inexperienced stroke centre can rapidly implement the necessary logistics to deliver thrombolysis to a large proportion of patients with acute stroke with short hospital delays. Important factors are probably prenotification of a team and the initiation of thrombolytic treatment in the emergency room.
引用
收藏
页码:324 / 326
页数:3
相关论文
共 6 条
  • [1] Early intravenous thrombolysis for acute ischemic stroke in a community-based approach
    Grond, M
    Stenzel, C
    Schmülling, S
    Rudolf, J
    Neveling, M
    Lechleuthner, A
    Schneweis, S
    Heiss, WD
    [J]. STROKE, 1998, 29 (08) : 1544 - 1549
  • [2] Intravenous tissue-type plasminogen activator therapy for ischemic stroke - Houston experience 1996 to 2000
    Grotta, JC
    Burgin, WS
    El-Mitwalli, A
    Long, M
    Campbell, M
    Morgenstern, LB
    Malkoff, M
    Alexandrov, AV
    [J]. ARCHIVES OF NEUROLOGY, 2001, 58 (12) : 2009 - 2013
  • [3] Door to thrombolysis:: ER reorganization and reduced delays to acute stroke treatment
    Lindsberg, P. J.
    Haeppoelae, O.
    Kallela, M.
    Valanne, L.
    Kuisma, M.
    Kaste, M.
    [J]. NEUROLOGY, 2006, 67 (02) : 334 - 336
  • [4] Population-based analysis of the impact of expanding the time window for acute stroke treatment
    Majersik, Jennifer Juhl
    Smith, Melinda A.
    Zahuranec, Darin B.
    Sanchez, Brisa N.
    Morgenstern, Lewis B.
    [J]. STROKE, 2007, 38 (12) : 3213 - 3217
  • [5] The yield of expanding the therapeutic time window for tPA
    Owe, J. F.
    Sanaker, P. S.
    Naess, H.
    Thomassen, L.
    [J]. ACTA NEUROLOGICA SCANDINAVICA, 2006, 114 (05): : 354 - 357
  • [6] Thrombolysis with alteplase for acute ischaemic stroke in the Safe implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST):: an observational study
    Wahlgren, Nils
    Ahmed, Niaz
    Davalos, Antoni
    Ford, Gary A.
    Grond, Martin
    Hacke, Werner
    Hennerici, Michael G.
    Kaste, Markku
    Kuelkens, Sonja
    Larrue, Vincent
    Lees, Kennedy R.
    Roine, Risto O.
    Soinne, Lauri
    Toni, Danilo
    Vanhooren, Geert
    [J]. LANCET, 2007, 369 (9558) : 275 - 282